Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up.

Carroll P; Coley C; McLeod D; Schellhammer P; Sweat G; Wasson J; Zietman A; Thompson I

首页> 外文期刊>Urology >Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up.

【24h】

Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up.

机译：前列腺特异性抗原最佳实践策略-第二部分：前列腺癌分期和治疗后的随访。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Urology》 |2001年第2期|共5页
作者
Carroll P; Coley C; McLeod D; Schellhammer P; Sweat G; Wasson J; Zietman A; Thompson I;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科学;
关键词
Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms; 肿瘤分期; 前列腺特异抗原; 前列腺肿瘤;

机译：Neoplasm Staging;Prostate-Specific Antigen;Prostatic Neoplasms;肿瘤分期;前列腺特异抗原;前列腺肿瘤;

相似文献

外文文献
中文文献
专利

1. Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up. [J] . Carroll P, Coley C, McLeod D, Urology . 2001,第2期

机译：前列腺特异性抗原最佳实践策略-第二部分：前列腺癌分期和治疗后的随访。
2. Prostate-specific antigen density adjusted for the transition zone for staging clinically localized prostate cancer in Japanese patients with intermediate serum prostate-specific antigen levels. [J] . Furuya Y, Ohta S, Sato N, Anticancer Research: International Journal of Cancer Research and Treatment . 2001,第2B期

机译：在过渡血清区中调整前列腺特异性抗原密度，以在中等血清前列腺特异性抗原水平的日本患者中分期临床定位的前列腺癌。
3. Unexpected significant findings non-related to prostate cancer identified using combined prostate-specific membrane antigen positron emission tomography/CT and diagnostic CT scan in primary staging for prostate cancer [J] . McEwan Louise, McBean Rhiannon, Yaxley John, Journal of medical imaging and radiation oncology . 2019,第3期

机译：意外的重要发现与使用组合前列腺特异性膜抗原正电子发射断层扫描/ CT和诊断CT扫描的前列腺癌无关，在前列腺癌的主要分期中
4. Analysis of glycoforms of urinary prostate-specific antigen of prostate cancer and benign prostate hyperplasia samples [C] . Chun-Jen Hsiao, Tzong-Shin Tzai, Chein-Hung Chen, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：前列腺癌和良性前列腺增生样品的尿道前列腺特异性抗原糖族分析
5. Studies on human prostate-specific antigen as a tumor antigen for the immunotherapy of prostate cancer in a mouse model. [D] . Willis, Richard Allen. 2002

机译：人类前列腺特异性抗原作为一种肿瘤抗原的免疫模型在小鼠模型中的研究。
6. Diagnostic Performance of 68Gallium Labelled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging for Staging the Prostate Cancer with Intermediate or High Risk Prior to Radical Prostatectomy: A Systematic Review and Meta-analysis [O] . Hui Wu, Ting Xu, Xiao Wang, 2020

机译：68G标记前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描和磁共振成像对根治性前列腺切除术中高危前列腺癌的诊断性能：系统评价和荟萃分析
7. Molecular staging of prostatic cancer with RT-PCR assay for prostate-specific antigen in peripheral blood and lymph nodes: Comparison with standard histological staging and immunohistochemical assessment of occult regional lymph node metastases [O] . Martínez-Piñeiro Luis, Martínez-Gomariz Montserrat, Palacios José, 2013

机译：RT-PCR测定前列腺癌在外周血和淋巴结中的抗原的分子分期：与标准组织学分期和隐匿性区域淋巴结转移的免疫组织化学比较

Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up.

著录项

相似文献

相关主题

期刊订阅